How has Pulse Biosciences, Inc.'s other commercial liabilities changed year-over-year?

Pulse Biosciences, Inc.'s other commercial liabilities increased by 35.7% year-over-year, from $3.98M to $5.41M.

What is the long-term trend for Pulse Biosciences, Inc.'s other commercial liabilities?

Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s other commercial liabilities has grown at a -7.7% compound annual growth rate (CAGR), from $5.33M to $3.58M.

Pulse Biosciences, Inc. PLSE Other Commercial Liabilities

Other Commercial Liabilities at other companies

Johnson & JohnsonJNJ

——

Boston ScientificBSX

——

Merit Medical SystemsMMSI

——

ITG

Integer HoldingsITGR

——

LivaNovaLIVN

——

Celldex TherapeuticsCLDX

——

Other financials

Income statement

See full

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Balance sheet

See full

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Total assets$81.6M-38.8%

Cash flow

See full

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Valuation

See full

Market cap$1.8B+38.4%

Enterprise value$1.73B+48.1%

P/S2,391.5×—

Profitability

See full

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

FCF margin-7,390%—

Returns & leverage

See full

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s other commercial liabilities?: Pulse Biosciences, Inc. (PLSE) reported other commercial liabilities of $5.41M in Q1 2026.
How has Pulse Biosciences, Inc.'s other commercial liabilities changed year-over-year?: Pulse Biosciences, Inc.'s other commercial liabilities increased by 35.7% year-over-year, from $3.98M to $5.41M.
What is the long-term trend for Pulse Biosciences, Inc.'s other commercial liabilities?: Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s other commercial liabilities has grown at a -7.7% compound annual growth rate (CAGR), from $5.33M to $3.58M.